These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33439570)

  • 1. Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study.
    Palumbo C; Bruni A; Antonelli A; Artibani W; Bassi P; Bertoni F; Borghetti P; Bracarda S; Cicchetti A; Corvò R; Gacci M; Ingrosso G; Magrini SM; Maruzzo M; Mirone V; Montironi R; Muto G; Noale M; Porreca A; Russi E; Triggiani L; Tubaro A; Valdagni R; Maggi S; Conti GN;
    Minerva Urol Nephrol; 2022 Feb; 74(1):11-20. PubMed ID: 33439570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.
    Lubeck DP; Grossfeld GD; Carroll PR
    Urology; 2001 Aug; 58(2 Suppl 1):94-100. PubMed ID: 11502459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR).
    Buglione M; Noale M; Bruni A; Antonelli A; Bertoni F; Corvo' R; Ricardi U; Borghetti P; Maddalo M; Simeone C; Mazzeo E; Porreca A; Serni S; Bassi P; Gacci M; Mirone V; Montironi R; Tubaro A; Berruti A; Conti GN; Maggi S; Magrini SM; Triggiani L;
    PLoS One; 2019; 14(11):e0224151. PubMed ID: 31675380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' desire to preserve sexual activity and final decision for a nerve-sparing approach: results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study.
    Imbimbo C; Creta M; Gacci M; Simonato A; Gontero P; de Cobelli O; Briganti A; Fulcoli V; Martorana G; Nicita G; Mirone V; Carmignani G
    J Sex Med; 2011 May; 8(5):1495-502. PubMed ID: 21324091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual Rehabilitation After Nerve-Sparing Radical Prostatectomy: Free-of-Charge Phosphodiesterase Type 5 Inhibitor Administration Improves Compliance to Treatment.
    Siena G; Mari A; Canale A; Mondaini N; Chindemi A; Greco I; Saleh O; Serni S; Nicita G; Minervini A; Carini M
    J Sex Med; 2018 Feb; 15(2):120-123. PubMed ID: 29425663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study.
    Porreca A; Noale M; Artibani W; Bassi PF; Bertoni F; Bracarda S; Conti GN; Corvò R; Gacci M; Graziotti P; Magrini SM; Mirone V; Montironi R; Muto G; Pecoraro S; Ricardi U; Russi E; Tubaro A; Zagonel V; Crepaldi G; Maggi S;
    Health Qual Life Outcomes; 2018 Jun; 16(1):122. PubMed ID: 29898750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
    Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasis, Mortality, and Quality of Life for Men With NCCN High and Very High Risk Localized Prostate Cancer After Surgical and/or Combined Modality Radiotherapy.
    Tward JD; O'Neil B; Boucher K; Kokeny K; Lowrance WT; Lloyd S; Cannon D; Stephenson RA; Agarwal N; Farr T; Petragallo R; Sherar NZ; Kunz I; Hofer A; Courdy S; Shrieve DC; Dechet C
    Clin Genitourin Cancer; 2020 Aug; 18(4):274-283.e5. PubMed ID: 32335059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study).
    Antonelli A; Palumbo C; Noale M; Artibani W; Bassi P; Bertoni F; Bracarda S; Bruni A; Corvò R; Gacci M; Magrini SM; Montironi R; Porreca A; Tubaro A; Zagonel V; Maggi S;
    Minerva Urol Nefrol; 2020 Oct; 72(5):595-604. PubMed ID: 31920063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-perceived satisfaction after definitive treatment for men with high-risk prostate cancer: radical prostatectomy vs. intensity-modulated radiotherapy with androgen deprivation therapy.
    Yamamoto S; Masuda H; Urakami S; Fujii Y; Sakamoto K; Kozuka T; Oguchi M; Fukui I; Yonese J
    Urology; 2015 Feb; 85(2):407-13. PubMed ID: 25623703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study.
    Eisemann N; Nolte S; Schnoor M; Katalinic A; Rohde V; Waldmann A
    BMC Urol; 2015 Apr; 15():28. PubMed ID: 25885890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.
    Choo R; Pearce A; Danjoux C; Morton G; Deboer G; Szumacher E; Loblaw A; Cheung P
    Eur Urol; 2007 Dec; 52(6):1645-50. PubMed ID: 17140722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study).
    Antonelli A; Palumbo C; Noale M; Porreca A; Maggi S; Simeone C; Bassi P; Bertoni F; Bracarda S; Buglione M; Conti GN; Corvò R; Gacci M; Mirone V; Montironi R; Triggiani L; Tubaro A; Artibani W;
    Urol Int; 2019; 103(1):8-18. PubMed ID: 30731456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy.
    Adam M; Tennstedt P; Lanwehr D; Tilki D; Steuber T; Beyer B; Thederan I; Heinzer H; Haese A; Salomon G; Budäus L; Michl U; Pehrke D; Stattin P; Bernard J; Klaus B; Pompe RS; Petersen C; Huland H; Graefen M; Schwarz R; Huber W; Loeb S; Schlomm T
    Eur Urol; 2017 Mar; 71(3):330-336. PubMed ID: 27887941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control study.
    Houédé N; Rébillard X; Bouvet S; Kabani S; Fabbro-Peray P; Trétarre B; Ménégaux F
    BMC Cancer; 2020 Aug; 20(1):757. PubMed ID: 32787797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
    Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
    Denham JW; Wilcox C; Joseph D; Spry NA; Lamb DS; Tai KH; Matthews J; Atkinson C; Turner S; Christie D; Gogna NK; Kenny L; Duchesne G; Delahunt B; McElduff P
    Lancet Oncol; 2012 Dec; 13(12):1260-70. PubMed ID: 23151431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in long-term prostate cancer survivors after nerve-sparing and non-nerve-sparing radical prostatectomy-Results from the multiregional PROCAS study.
    Adam S; Martin-Diener E; Camey B; Egger Hayoz C; Konzelmann I; Mohsen Mousavi S; Herrmann C; Rohrmann S; Wanner M; Staehelin K; Strebel RT; Randazzo M; John H; Schmid HP; Arndt V
    Cancer Med; 2020 Aug; 9(15):5416-5424. PubMed ID: 32524704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytoreductive radical prostatectomy for prostate cancer with minimal osseous metastases: results of a first feasibility and case control study].
    Heidenreich A; Pfister D; Brehmer B; Porres D
    Urologe A; 2015 Jan; 54(1):14-21. PubMed ID: 25519996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.